发明名称 Extended length botulinum toxin formulation for human or mammalian use
摘要 An extended duration pharmaceutical composition including a botulinum neurotoxin, an adhesive agent, and a stabilizing macromolecule. The composition effectively has all the properties to cause chemodenervation through a facial muscle, or other muscle, that predecessor botulinum toxin preparations have had as well as agents which create a fibrotic adhesion on the under surface of facial muscles (or other muscles) to the facial bone (or other bones) so that the facial bone tethers the under surface of the facial muscle, thereby causing fibrosis to the underlying fat pad. The composition can be used to treat various disorders. Methods of modifying facial contour for functional or cosmetic purposes in a human patient are disclosed which involve injecting a therapeutically effective amount of the disclosed compositions. A method of quantifying the extended duration of the compositions is also disclosed.
申请公布号 US9066851(B2) 申请公布日期 2015.06.30
申请号 US200913132855 申请日期 2009.12.04
申请人 Botulinum Toxin Research Associates, Inc. 发明人 Borodic Gary E.
分类号 A61K38/16;A61K9/00;A61K8/02;A61K8/24;A61K8/33;A61K8/55;A61K8/64;A61K8/65;A61K8/81;A61K9/08;A61K38/48;A61K47/08;A61K47/10;A61K47/24;A61K47/32;A61K47/42;A61Q19/08 主分类号 A61K38/16
代理机构 Milbank, Tweed, Hadley & McCloy LLP 代理人 Milbank, Tweed, Hadley & McCloy LLP
主权项 1. A pharmaceutical composition comprising a botulinum neurotoxin, an adhesive agent, and one or more stabilizing macromolecules, wherein the adhesive agent is a sequentially or simultaneously administered preparation containing fibrinogen and thrombin, and wherein the one or more stabilizing macromolecules comprises a stabilizing polysaccharide.
地址 Quincy MA US